Skip to content

Prevalence of Metabolic Syndrome in a Maintenance Hemodialysis Population

Prevalence of Metabolic Syndrome in a Maintenance Hemodialysis Population

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01176630
Enrollment
108
Registered
2010-08-06
Start date
2010-08-31
Completion date
2010-12-31
Last updated
2012-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Keywords

metabolic syndrome, ESRD patient

Brief summary

The study is a survey to answer the specific question, What is the prevalence of metabolic syndrome in maintenance hemodialysis patients? Metabolic syndrome is a cluster of conditions that increase an individual's risk for developing cardiovascular disease and diabetes.

Detailed description

Risk factors for metabolic syndrome will be collected for each consented patient. They include elevated serum triglycerides, reduced HDL cholesterol, hypertension, elevated fasting blood sugar concentration and abdominal obesity. The investigator will measure waist circumference of each consented patient in a secure area according to standardized procedures. The other data is available from the patient's medical record.

Interventions

None listed

Sponsors

Winthrop University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients undergoing maintenance hemodialysis equal to or greater than 3 months * Patient at lest 18 years of age * Availability of all data in the medical record for classification of the metabolic syndrome, including serum triglycerides, serum HDL-cholesterol, systolic BP and diastolic BP, and serum glucose

Exclusion criteria

* Patients unwilling or unable to give informed consent to participate * Patients with a history of thyroid disease * Patients unable to stand upright

Design outcomes

Primary

MeasureTime frame
Percent of maintenance patients with at least three risk factors of metabolic syndrome6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026